Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03814356
PHASE1
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
Phase 1 of the STIMPACT trial is an open label,dose-escalation,safety study of intravenous (IV) methylphenidate (MPH) therapy in patients with disorders of consciousness (DoC) caused by severe brain injuries.
Official title: Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness - A Phase 1 Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2020-08-24
Completion Date
2026-06-30
Last Updated
2025-10-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
Methylphenidate
IV MPH
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States